Could a Light-Based blood treatment help early skin cancer patients?

NCT ID NCT05680558

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 33 times

Summary

This study tests whether a treatment called photopheresis, which filters and treats a patient's blood with light, can help people with early-stage cutaneous T-cell lymphoma (a type of skin cancer). Currently used only for advanced disease, researchers want to see if using it earlier improves skin clearing. About 74 adults with stage IA to IIA mycosis fungoides will receive the therapy and be followed for one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS T-CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Columbia University Irving Medical Center

    RECRUITING

    New York, New York, 10032, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.